Document is current
Any future updates will be listed below
-
Authors
Dou, Zhixun https://orcid.org/0000-0002-3069-3907
Kreiling, Jill A https://orcid.org/0000-0003-4440-2039
Heynen-Genel, Susanne
Jurk, Diana
Neretti, Nicola
Adams, Peter D
Sedivy, John M
Passos, João F https://orcid.org/0000-0001-8765-1890
-
Funding
Funding for this research was provided by:
HHS | National Institutes of Health (R01AG068048,R01AG82708,UG3/UH3CA268103 08)
HHS | National Institutes of Health (R01AG082785,R35GM137889,UG3/UH3CA268117)
HHS | National Institutes of Health (R01AG016694,R01AG078,P01AG051449 925)
HHS | National Institutes of Health (R01AG074284)
HHS | National Institutes of Health (P01AG031862,R01AG071861)
HHS | National Institutes of Health (UG3/UH3CA268202)
HHS | National Institutes of Health (R01AG068182)
HHS | National Institutes of Health (P01AG062413, R01AG078925)
Glenn Foundation for Medical Research
American Federation for Aging Research /Hevolution
- License Information
-
More Information
Article History
Received: 18 July 2025
Revised: 28 July 2025
Accepted: 29 July 2025
First Online: 29 August 2025
Disclosure and competing interest statement
: JMS is a cofounder and SAB chair of Transposon Therapeutics. The remaining authors declare no competing interests.
